On July 3, 2017, the board of directors of WAVE Life Sciences Ltd. announced that Masaharu Tanaka has decided to retire from the board and therefore will not be seeking re-election when his term expires at its upcoming 2017 annual general meeting of shareholders. Mr. Tanaka joined the Board in connection with Kagoshima Shinsangyo Sousei Investment Limited Partnership’s initial investment in the company and he helped transition of the company to become a publicly traded company in 2015.